Lab
Prymed Medical Care INC
Prymed Medical Care INC was paid $824K by Medicaid between Jan 2018 and Oct 2024, across 61 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 15% of everything it billed.
33Billing provider infoPRYMED MEDICAL CARE INC
VEGA BAJA, PR 00693
VEGA BAJA, PR 00693
33aNPI1174914154assigned 02/11/2015
33bProvider typeClinical Medical Laboratory
28Total paid$824K
24GClaims79,947
24DCodes billed61
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#158 of 777
Median peer was paid$278K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,886 | $65K | |
| 2019 | 6,334 | $65K | |
| 2020 | 6,908 | $69K | |
| 2021 | 15,386 | $158K | |
| 2022 | 14,603 | $172K | |
| 2023 | 15,481 | $153K | |
| 2024incomplete | 14,349 | $143K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 8,068 | 7,616 | $126K |
| 80061 | Lipid panel | 12% | 7,945 | 7,544 | $99K |
| 80053 | Comprehensive metabolic panel | 10% | 8,774 | 8,314 | $86K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.9% | 10,100 | 9,497 | $73K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.5% | 2,123 | 2,009 | $54K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.1% | 1,023 | 988 | $42K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.9% | 1,675 | 1,551 | $40K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.6% | 4,248 | 4,035 | $38K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.0% | 667 | 623 | $33K |
| 84439 | 3.6% | 3,136 | 2,961 | $30K | |
| 36415 | Collection of venous blood by venipuncture | 2.8% | 9,784 | 8,905 | $23K |
| 82274 | 2.7% | 1,533 | 1,430 | $22K |
49 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.1% | 567 | $18K |
| 81001 | 1.9% | 4,766 | $16K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.8% | 667 | $15K |
| 87590 | 1.5% | 634 | $12K | |
| 81000 | 1.4% | 3,837 | $11K | |
| 86580 | 1.2% | 1,346 | $10K | |
| 86592 | 1.1% | 2,273 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 174 | $9K |
| 84153 | <1% | 463 | $8K | |
| 87088 | <1% | 916 | $7K | |
| 87485 | <1% | 256 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 232 | $4K |
| 86738 | <1% | 213 | $3K | |
| 86701 | <1% | 247 | $2K | |
| 86800 | <1% | 147 | $2K | |
| 87177 | <1% | 182 | $2K | |
| 80074 | <1% | 45 | $2K | |
| 87070 | <1% | 256 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 253 | $2K |
| 82947 | <1% | 560 | $2K | |
| 82043 | <1% | 289 | $2K | |
| 87899 | <1% | 150 | $2K | |
| 82044 | <1% | 391 | $2K | |
| 86803 | <1% | 112 | $1K | |
| 87490 | <1% | 65 | $1K | |
| 82570 | <1% | 223 | $1K | |
| 86703 | <1% | 88 | $1K | |
| 86790 | <1% | 79 | $950.81 | |
| 84403 | <1% | 39 | $949.64 | |
| 83655 | <1% | 72 | $936.49 | |
| 83001 | <1% | 52 | $921.43 | |
| 86376 | <1% | 61 | $817.72 | |
| 85651 | <1% | 248 | $808.98 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 21 | $673.50 |
| 80069 | <1% | 71 | $484.96 | |
| 85730 | <1% | 80 | $462.45 | |
| 86038 | <1% | 40 | $441.44 | |
| 82607 | <1% | 28 | $414.94 | |
| 85610 | <1% | 92 | $349.86 | |
| 87276 | <1% | 16 | $212.60 | |
| 87275 | <1% | 16 | $212.60 | |
| 82950 | <1% | 43 | $196.75 | |
| 85018 | <1% | 67 | $104.67 | |
| 82270 | <1% | 32 | $93.00 | |
| 83540 | <1% | 13 | $81.99 | |
| 84550 | <1% | 12 | $54.69 | |
| 86140 | <1% | 14 | $48.54 | |
| 84479 | <1% | 147 | $44.07 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 276 | $0.09 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVEGA, MARISOL (FINANCE DIRECTOR)